These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4603299)

  • 1. [A double-blind comparison of josamycin propionate and erythromycin ethylsuccinate in the treatment of scarlet fever with their oral suspension preparations (author's transl)].
    Nakamizo Y; Akiba T; Tomizawa I; Tsuji M; Sato M
    Jpn J Antibiot; 1974 Apr; 27(2):73-85. PubMed ID: 4603299
    [No Abstract]   [Full Text] [Related]  

  • 2. [Josamycin propionate in the treatment of acute respiratory infections in children].
    Kobayashi Y; Akaishi K; Nishio T; Aihara M
    Jpn J Antibiot; 1973 Jun; 26(3):267-76. PubMed ID: 4542549
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of josamycin for the treatment of scarlet fever and hemolytic-streptococcal tonsillitis].
    Yanagishita T; Shimizu N; Ono T
    Nihon Densenbyo Gakkai Zasshi; 1969 Nov; 43(8):205-12. PubMed ID: 4983145
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug sensitivity of Streptococcus haemolyticus ecently isolated from patients with scarlet fever with special reference to the advent of an erythromycin-resistant strain].
    Misuno K; Hirayama A; Yoshida R
    Kansenshogaku Zasshi; 1972 Mar; 46(3):80-2. PubMed ID: 4625362
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the relationship of hemolytic Streptococcus isolated from scarlet fever patients and their families (author's transl)].
    Iimura T; Shimitsu N; Yanagishita T; Wada H; Niwano K; Tanaka M; Nagase K; Ohkubo N; Kashiwagi Y; Shibata M
    Kansenshogaku Zasshi; 1979 Oct; 53(10):564-74. PubMed ID: 119014
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience with amoxicillin tablets in the field of pediatrics (author's transl)].
    Saito Y; Koga M
    Jpn J Antibiot; 1978 Apr; 31(4):218-24. PubMed ID: 248065
    [No Abstract]   [Full Text] [Related]  

  • 7. [Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections].
    Bertrand A; Jonquet O; Sauvaget J
    Pathol Biol (Paris); 1988 May; 36(5):544-7. PubMed ID: 3043354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recurrent attacks of scarlet fever and penicillin treatment (author's transl)].
    Kucera H; Bauer P
    Wien Klin Wochenschr; 1974 Sep; 86(16):452-6. PubMed ID: 4428771
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibiotic therapy of scarlet fever].
    Iimura I; Shimizu H; Hirayama A; Yamaguchi T; Tomisawa I
    Kansenshogaku Zasshi; 1973 Dec; 47(12):536-9. PubMed ID: 4208604
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythromycin-resistant Streptococcus viridans in oral flora with prolonged erythromycin therapy.
    Bromberg K; Orson JM; Triedman R; Campognone P
    Ann Intern Med; 1980 Dec; 93(6):931-2. PubMed ID: 6449896
    [No Abstract]   [Full Text] [Related]  

  • 11. [A double blind comparative study of bacampicillin and talampicillin on scarlet fever (author's transl)].
    Tomizawa I; Murata M; Tsuji M; Yamaguchi T; Yanagishita T; Nakazawa H; Shimizu N; Isogai H; Wada H; Seo T; Niwano K; Matsubara Y; Iimura T; Hoshino S; Ookubo N; Kashiwagi Y; Shibata M; Nagase K; Arai H; Tanaka T; Kuwahara S
    Kansenshogaku Zasshi; 1979 Mar; 53(3):121-38. PubMed ID: 112197
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of scarlet fever of children with new oral cephalosporin granules (S-640 P or cefatrizine granules) (author's transl)].
    Sato H; Nakazawa S; Chikaoka H; Yamaguchi T
    Jpn J Antibiot; 1976 Feb; 29(2):184-88. PubMed ID: 772247
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on josamycin propionate. VII. Prolonged oral administration in dogs (author's transl)].
    Tachibana A; Komiya M; Sado T; Yano K
    Jpn J Antibiot; 1974 Aug; 27(4):532-8. PubMed ID: 4436959
    [No Abstract]   [Full Text] [Related]  

  • 14. Macrolides and changes in the oral flora.
    Sefton AM
    Int J Antimicrob Agents; 1999 Mar; 11 Suppl 1():S23-9; discussion S31-2. PubMed ID: 10204636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibility of beta-hemolytic streptococci to antibiotics and alternative drugs].
    Kondrakova OA; Eshchina AS; Dmitrieva NF; Briko NI; Babin VN
    Antibiot Khimioter; 1998; 43(7):26-30. PubMed ID: 9727164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology of group A streptococcus causing scarlet fever in northern Taiwan, 2001-2002.
    Chen YY; Huang CT; Yao SM; Chang YC; Shen PW; Chou CY; Li SY
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):289-95. PubMed ID: 17532590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The macrolide antibiotics. Pharmacological bases, recent acquisitions and personal experiences in infectious pathology].
    Mingrino F; Altieri T; Andreuzzi A; Viola F
    Minerva Pediatr; 1979 Apr; 31(7):549-67. PubMed ID: 460106
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent attacks of scarlet fever.
    Chiesa C; Pacifico L; Nanni F; Orefici G
    Arch Pediatr Adolesc Med; 1994 Jun; 148(6):656-60. PubMed ID: 8193698
    [No Abstract]   [Full Text] [Related]  

  • 19. [The value of targeted antibiotic therapy based on the example of streptococcal infections with special reference to late side effects].
    Zechner G
    Wien Med Wochenschr; 1983; 133 Suppl 1():17-21. PubMed ID: 6559004
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.
    Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J
    Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.